Multicenter, Phase IV evaluation of intravenous cirpfloxacin as initial therapy in patients with lower respiratory tract, urinary tract, and skin/skin structure infections-Reference-Cited by-同舟云学术

Multicenter, Phase IV evaluation of intravenous cirpfloxacin as initial therapy in patients with lower respiratory tract, urinary tract, and skin/skin structure infections

Published:1995-05 Issue:3 Volume:17 Page:353-365
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Pankey George A.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference52 articles.

1. Fluoroquinolone antimicrobial agents;Wolfson;Clin Microbiol Rev,1989

2. Fluoroquinolone antimicrobial agents;Hooper;NEJM,1991

3. The role of fluoroquinolones;Guay;Pharmacotherapy,1992

4. Ciprofloxacin. A review of its pharmacological profile and therapeutic use in the elderly;Wiseman;Drugs Aging,1994

5. Oral ciprofloxacin. A pharmacoeconomic evaluation of its use in the treatment of serious infections;Balfour;PharmacoEconomics,1993

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neutropenic Rat Thigh Infection Model for Evaluation of the Pharmacokinetics/Pharmacodynamics of Anti-Infectives;Microbiology Spectrum;2023-08-17

2. Preserving the efficacy of front-line fluoroquinolones through selective use to optimise clinical outcomes;International Journal of Antimicrobial Agents;2014-06

3. Gender Analysis of Moxifloxacin Clinical Trials;Journal of Women's Health;2014-01

4. Intravenous or Sequential Ciprofloxacin Therapy in Hospitalised??Patients with a Broad??Spectrum??of Infections;Clinical Drug Investigation;2006

5. The use of fluoroquinolones in the treatment of skin infections;Expert Opinion on Pharmacotherapy;2004-02